High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$866K
$866,971
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
WVE
S
Wave Life Sciences Ltd.
Francis Chris
• Officer • See Remarks
10b5-1 SellΔOwn -19.8%
2026-02-26
$499,593x2
|
||||||
| WVE |
Wave Life Sciences Ltd.
|
Officer • See Remarks
10b5-1 SellΔOwn -19.8%
|
2026-02-26 | $499,593x2 | S | Form 4 |
| WVE |
Wave Life Sciences Ltd.
|
CEO
Sell to Cover
|
2026-02-09 | $140,956 | S | Form 4 |
|
WVE
S
Wave Life Sciences Ltd.
Francis Chris
• Officer • See Remarks
Sell to Cover
2026-02-09
$25,326
|
||||||
| WVE |
Wave Life Sciences Ltd.
|
Officer • See Remarks
Sell to Cover
|
2026-02-09 | $25,326 | S | Form 4 |
| WVE |
Wave Life Sciences Ltd.
|
CFO
Sell to Cover
|
2026-02-09 | $48,259 | S | Form 4 |
|
WVE
S
Wave Life Sciences Ltd.
Vargeese Chandra
• Officer • See Remarks
Sell to Cover
2026-02-09
$43,417
|
||||||
| WVE |
Wave Life Sciences Ltd.
|
Officer • See Remarks
Sell to Cover
|
2026-02-09 | $43,417 | S | Form 4 |
|
WVE
S
Wave Life Sciences Ltd.
Rawcliffe Adrian
• Director
10b5-1 SellΔOwn -55.9%
2025-11-13
$109,421
|
||||||
| WVE |
Wave Life Sciences Ltd.
|
Director
10b5-1 SellΔOwn -55.9%
|
2025-11-13 | $109,421 | S | Form 4 |